128 related articles for article (PubMed ID: 28115060)
21. Molecular features of thyroid oncocytic tumors.
Gasparre G; Bonora E; Tallini G; Romeo G
Mol Cell Endocrinol; 2010 May; 321(1):67-76. PubMed ID: 20184940
[TBL] [Abstract][Full Text] [Related]
22. MIEAP and ATG5 are tumor suppressors in a mouse model of BRAF
Hamada K; Kurashige T; Shimamura M; Arakawa H; Nakamura Y; Nagayama Y
Front Endocrinol (Lausanne); 2022; 13():932754. PubMed ID: 36187114
[TBL] [Abstract][Full Text] [Related]
23. Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma.
Mayr JA; Meierhofer D; Zimmermann F; Feichtinger R; Kögler C; Ratschek M; Schmeller N; Sperl W; Kofler B
Clin Cancer Res; 2008 Apr; 14(8):2270-5. PubMed ID: 18413815
[TBL] [Abstract][Full Text] [Related]
24. Cancer metabolism in space and time: Beyond the Warburg effect.
Danhier P; Bański P; Payen VL; Grasso D; Ippolito L; Sonveaux P; Porporato PE
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):556-572. PubMed ID: 28167100
[TBL] [Abstract][Full Text] [Related]
25. Oncocytic tumors are marked by enhanced mitochondrial content and mtDNA mutations of complex I in Chinese patients.
Lyu L; Wang Q; Song S; Li L; Zhou H; Li M; Jiang Z; Zhou C; Chen G; Lyu J; Bai Y
Mitochondrion; 2019 Mar; 45():1-6. PubMed ID: 29386142
[TBL] [Abstract][Full Text] [Related]
26. Defective mitochondrial ATP synthesis in oxyphilic thyroid tumors.
Savagner F; Franc B; Guyetant S; Rodien P; Reynier P; Malthiery Y
J Clin Endocrinol Metab; 2001 Oct; 86(10):4920-5. PubMed ID: 11600563
[TBL] [Abstract][Full Text] [Related]
27. Calcium regulates cell death in cancer: Roles of the mitochondria and mitochondria-associated membranes (MAMs).
Danese A; Patergnani S; Bonora M; Wieckowski MR; Previati M; Giorgi C; Pinton P
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):615-627. PubMed ID: 28087257
[TBL] [Abstract][Full Text] [Related]
28. Hürthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance.
Máximo V; Sobrinho-Simões M
Virchows Arch; 2000 Aug; 437(2):107-15. PubMed ID: 10993269
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional profiling reveals coordinated up-regulation of oxidative metabolism genes in thyroid oncocytic tumors.
Baris O; Savagner F; Nasser V; Loriod B; Granjeaud S; Guyetant S; Franc B; Rodien P; Rohmer V; Bertucci F; Birnbaum D; Malthièry Y; Reynier P; Houlgatte R
J Clin Endocrinol Metab; 2004 Feb; 89(2):994-1005. PubMed ID: 14764826
[TBL] [Abstract][Full Text] [Related]
30. A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors.
Evangelisti C; de Biase D; Kurelac I; Ceccarelli C; Prokisch H; Meitinger T; Caria P; Vanni R; Romeo G; Tallini G; Gasparre G; Bonora E
BMC Cancer; 2015 Mar; 15():157. PubMed ID: 25880213
[TBL] [Abstract][Full Text] [Related]
31. Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors.
Gasparre G; Porcelli AM; Bonora E; Pennisi LF; Toller M; Iommarini L; Ghelli A; Moretti M; Betts CM; Martinelli GN; Ceroni AR; Curcio F; Carelli V; Rugolo M; Tallini G; Romeo G
Proc Natl Acad Sci U S A; 2007 May; 104(21):9001-6. PubMed ID: 17517629
[TBL] [Abstract][Full Text] [Related]
32. Manipulation of tumor oxygenation and radiosensitivity through modification of cell respiration. A critical review of approaches and imaging biomarkers for therapeutic guidance.
Gallez B; Neveu MA; Danhier P; Jordan BF
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):700-711. PubMed ID: 28088332
[TBL] [Abstract][Full Text] [Related]
33. Mitochondrial DNA mutations in oncocytic adnexal lacrimal glands of the conjunctiva.
Bartoletti-Stella A; Salfi NC; Ceccarelli C; Attimonelli M; Romeo G; Gasparre G
Arch Ophthalmol; 2011 May; 129(5):664-6. PubMed ID: 21555623
[No Abstract] [Full Text] [Related]
34. Early loss of mitochondrial complex I and rewiring of glutathione metabolism in renal oncocytoma.
Gopal RK; Calvo SE; Shih AR; Chaves FL; McGuone D; Mick E; Pierce KA; Li Y; Garofalo A; Van Allen EM; Clish CB; Oliva E; Mootha VK
Proc Natl Acad Sci U S A; 2018 Jul; 115(27):E6283-E6290. PubMed ID: 29915083
[TBL] [Abstract][Full Text] [Related]
35. Oncocytic lesions of the thyroid, kidney, salivary glands, adrenal cortex, and parathyroid glands.
Máximo V; Rios E; Sobrinho-Simões M
Int J Surg Pathol; 2014 Feb; 22(1):33-6. PubMed ID: 24406625
[TBL] [Abstract][Full Text] [Related]
36. Genomic and transcriptomic characterization of the mitochondrial-rich oncocytic phenotype on a thyroid carcinoma background.
Cavadas B; Pereira JB; Correia M; Fernandes V; Eloy C; Sobrinho-Simões M; Soares P; Samuels DC; Máximo V; Pereira L
Mitochondrion; 2019 May; 46():123-133. PubMed ID: 29631022
[TBL] [Abstract][Full Text] [Related]
37. Review of renal oncocytoma with focus on clinical and pathobiological aspects.
Kuroda N; Toi M; Hiroi M; Shuin T; Enzan H
Histol Histopathol; 2003 Jul; 18(3):935-42. PubMed ID: 12792905
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial activities of a cell line derived from thyroid Hürthle cell tumors.
Stankov K; Biondi A; D'Aurelio M; Gasparre G; Falasca A; Romeo G; Lenaz G
Thyroid; 2006 Apr; 16(4):325-31. PubMed ID: 16646677
[TBL] [Abstract][Full Text] [Related]
39. The genetic and metabolic signature of oncocytic transformation implicates HIF1alpha destabilization.
Porcelli AM; Ghelli A; Ceccarelli C; Lang M; Cenacchi G; Capristo M; Pennisi LF; Morra I; Ciccarelli E; Melcarne A; Bartoletti-Stella A; Salfi N; Tallini G; Martinuzzi A; Carelli V; Attimonelli M; Rugolo M; Romeo G; Gasparre G
Hum Mol Genet; 2010 Mar; 19(6):1019-32. PubMed ID: 20028790
[TBL] [Abstract][Full Text] [Related]
40. Mitochondrial activity in XTC.UC1 cells derived from thyroid oncocytoma.
Savagner F; Chevrollier A; Loiseau D; Morgan C; Reynier P; Clark O; Stepien G; Malthiery Y
Thyroid; 2001 Apr; 11(4):327-33. PubMed ID: 11349830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
